COX-2 INHIBITION IN THE ADJUVANT SETTING FOR COLORECTAL CANCER

COX-2 INHIBITION IN THE ADJUVANT SETTING FOR COLORECTAL CANCER

Bibliographic Details
Main Author:	Kerr, D
Format:	Conference item
Published:	2010

Similar Items

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
by: Kerr, D, et al.
Published: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
by: Kerr, D, et al.
Published: (2000)

New approaches for the treatment of colorectal cancer in the adjuvant setting
by: Kerr, D, et al.
Published: (2004)

Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
by: Sabharwal, A, et al.
Published: (2007)

Adjuvant therapy of colorectal cancer.
by: Midgley, R, et al.
Published: (2000)

Adjuvant chemotherapy for colorectal cancer.
by: Kerr, D, et al.
Published: (1996)

Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
by: Cascinu, S, et al.
Published: (2003)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
by: Johnstone, E, et al.
Published: (2008)

ABC of colorectal cancer: adjuvant therapy.
by: Midgley, R, et al.
Published: (2000)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
by: Midgley, R, et al.
Published: (2005)

A trial of adjuvant therapy in colorectal cancer: the VICTOR trial.
by: Pendlebury, S, et al.
Published: (2003)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
by: Midgley, R, et al.
Published: (2005)

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
by: Midgley, R, et al.
Published: (2010)

Protective effect of notoginsenoside and tanshinone IIA on inflammation-related colorectal cancer mice and the inhibition effect on COX-2 expression
by: Cao Wen, et al.
Published: (2021-03-01)

Expression of Beta-catenin, COX-2 and iNOS in Colorectal Cancer: Relevance of COX-2 and iNOS Inhibitors for Treatment in Malaysia
by: Seok Kwan Hong, et al.
Published: (2004-01-01)

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
by: Kerr, D, et al.
Published: (2007)

IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2
by: Yongkui Li, et al.
Published: (2018-08-01)

Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse.
by: Paul C Armstrong, et al.
Published: (2011-01-01)

Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.
by: Michelle A Carey, et al.
Published: (2010-07-01)

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
by: Gray, R, et al.
Published: (2007)

Viscum album-mediated COX-2 inhibition implicates destabilization of COX-2 mRNA.
by: Chaitrali Saha, et al.
Published: (2015-01-01)

COX-2 inhibition: a possible role in the management of prostate cancer?
by: Sooriakumaran, P, et al.
Published: (2007)

Correction to: IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2
by: Yongkui Li, et al.
Published: (2020-01-01)

Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway.
by: Xuan Liu, et al.
Published: (2015-01-01)

Expression and correlation of COX-2 and NUCB1 in colorectal adenocarcinoma
by: Yuanyuan Zhang, et al.
Published: (2023-07-01)

Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features
by: Sandhya VENKATACHALA, et al.
Published: (2017-09-01)

Inhibition of COX-2 signaling favors E. coli during urinary tract infection
by: Soumitra Mohanty, et al.
Published: (2023-09-01)

Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression
by: Harshit Shah, et al.
Published: (2021-09-01)

Preventive inositol hexaphosphate extracted from rice bran inhibits colorectal cancer through involvement of Wnt/β-catenin and COX-2 pathways
by: Shafie, Nurul Husna, et al.
Published: (2013)

Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition
by: Bostjan Humar, et al.
Published: (2008-06-01)

IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver Oligometastases
by: Miaoqing Wu, et al.
Published: (2023-03-01)

Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.
by: Ling Peng, et al.
Published: (2013-01-01)

Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients
by: Thorbjørn Søren Rønn Jensen, et al.
Published: (2018-02-01)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01)

YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
by: Wei Li, et al.
Published: (2017-10-01)

COLORECTAL CANCER
by: Kerr, D
Published: (2010)

Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001).
by: Van Cutsem, E, et al.
Published: (2002)

Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
by: Robert Ramer, et al.
Published: (2013-11-01)

Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis
by: Georgios D. Ayiomamitis, et al.
Published: (2019-10-01)

Calcitriol inhibits COX-1 and COX-2 expressions of renal vasculature in hypertension: Reactive oxygen species involved?
by: Zizheng Suo, et al.
Published: (2021-01-01)